Clinical Trial

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine if it is feasible to use magnetic resonance imaging (MRI) to adjust a portion of radiation therapy for patients with head and neck squamous cell carcinoma . The technique under study will be used to personalize the study treatment based on response, keeping all treatments within standard of care guidelines.
Protocol Amendment History 4 changes
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-04-02
notable Enrollment increased: 25 -> 35 participants 2026-04-02
notable Primary completion pushed: 2026-11 -> 2027-05 2026-04-02
minor Completion pushed: 2026-11 -> 2027-05 2026-04-02
Trial Details
NCT Number NCT06137274
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Conditions Squamous Cell Carcinoma, Head and Neck Cancer
Enrollment 35 participants
Start Date 2023-12-14
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-01